Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Immix Biopharma, Inc. (IMMX)

8.06 +0.86 (+11.94%)
At close: November 6 at 4:00:01 PM EST
7.99 -0.07 (-0.87%)
After hours: November 6 at 4:17:02 PM EST
Trade IMMX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
41,815.98
29,956.42
22,674.68
16,141.11
8,218.95
Operating Income
-41,815.98
-29,956.42
-22,674.68
-16,141.11
-8,218.95
Net Non Operating Interest Income Expense
1,932.08
555.53
1,017.35
572.01
-0.50
Pretax Income
-39,883.90
-29,400.89
-21,657.33
-15,569.11
-8,219.45
Tax Provision
33.31
37.72
41.04
26.42
10.27
Net Income Common Stockholders
-39,917.21
-29,438.61
-21,613.38
-15,426.05
-8,229.71
Diluted NI Available to Com Stockholders
-39,917.21
-29,438.61
-21,613.38
-15,426.05
-8,229.71
Basic EPS
-0.88
-0.89
-0.76
-0.89
-0.59
Diluted EPS
-0.88
-0.89
-0.76
-0.89
-0.59
Basic Average Shares
47,840.19
32,965.71
28,285.64
17,341.15
13,887.31
Diluted Average Shares
47,840.19
32,965.71
28,285.64
17,341.15
13,887.31
Total Operating Income as Reported
-41,815.98
-29,956.42
-22,674.68
-16,141.11
-8,218.95
Total Expenses
41,815.98
29,956.42
22,674.68
16,141.11
8,218.95
Net Income from Continuing & Discontinued Operation
-39,917.21
-29,438.61
-21,613.38
-15,426.05
-8,229.71
Normalized Income
-39,917.21
-29,438.61
-21,613.38
-15,426.05
-8,229.71
Interest Income
1,932.08
555.53
1,017.35
572.01
0
Interest Expense
--
--
--
0
0.50
Net Interest Income
1,932.08
555.53
1,017.35
572.01
-0.50
EBIT
-41,815.98
-29,956.42
-22,674.68
-16,141.11
-8,218.95
EBITDA
-41,328.85
-29,591.91
-22,559.29
-16,135.65
-8,216.81
Reconciled Depreciation
487.14
364.50
115.39
5.47
2.14
Net Income from Continuing Operation Net Minority Interest
-39,917.21
-29,438.61
-21,613.38
-15,426.05
-8,229.71
Total Unusual Items Excluding Goodwill
--
--
--
--
0
Total Unusual Items
--
--
--
--
0
Normalized EBITDA
-41,328.85
-29,591.91
-22,559.29
-16,135.65
-8,216.81
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 12/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: